1. A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. (April 2020) Authors: Alexander, Marliese; Pavlakis, Nick; John, Thomas; O'Connell, Rachel; Kao, Steven; Hughes, Brett G.M.; Lee, Adrian; Hayes, Sarah A.; Howell, Viive M.; Clarke, Stephen J.; Millward, Michael; Burbury, Kate; Solomon, Benjamin; Itchins, Malinda Journal: Lung cancer Issue: Volume 142(2020) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. Issue 11 (November 2017) Authors: Ahn, Myung-Ju; Kim, Dong-Wan; Cho, Byoung Chul; Kim, Sang-We; Lee, Jong Seok; Ahn, Jin-Seok; Kim, Tae Min; Lin, Chia-Chi; Kim, Hye Ryun; John, Thomas; Kao, Steven; Goldman, Jonathan W; Su, Wu-Chou; Natale, Ronald; Rabbie, Sarit; Harrop, Bryony; Overend, Philip; Yang, Zhenfan; Yang, James Chih-Hsin Journal: Lancet Issue: Volume 5:Issue 11(2017) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Issue 10 (October 2020) Authors: Marabelle, Aurélien; Fakih, Marwan; Lopez, Juanita; Shah, Manisha; Shapira-Frommer, Ronnie; Nakagawa, Kazuhiko; Chung, Hyun Cheol; Kindler, Hedy L; Lopez-Martin, Jose A; Miller, Wilson H; Italiano, Antoine; Kao, Steven; Piha-Paul, Sarina A; Delord, Jean-Pierre; McWilliams, Robert R; Fabrizio, Dav... Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: 1353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Case of post‐progression prolongation of survival after cessation of pembrolizumab in advanced non‐small‐cell lung cancer. Issue 6 (14th June 2020) Authors: Liu, Jia; Wong, Kirby; Patanjali, Nitya; Boyer, Michael; Kao, Steven Journal: Internal medicine journal Issue: Volume 50:Issue 6(2020) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials. Issue 3 (2nd March 2018) Authors: Prasanna, Thiru; Beith, Jane; Kao, Steven; Boyer, Michael; McNeil, Catriona M. Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14:Issue 3(2018) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dying of mesothelioma: A qualitative exploration of caregiver experiences. (20th June 2022) Authors: Lee, Jessica T.; Mittal, Dipti L.; Warby, Anne; Kao, Steven; Dhillon, Haryana M.; Vardy, Janette L. Journal: European journal of cancer care Issue: Volume 31:Number 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Eastern Cooperative Oncology Group score: Agreement between non-small-cell lung cancer patients and their oncologists and clinical implications. (2016) Authors: Malalasekera, Ashanya; Tan, Cindy Sim Y.; Phan, Viet; Yip, Po Yee; Vardy, Janette; Clarke, Stephen; Kao, Steven Journal: Cancer treatment communications Issue: Volume 5(2015) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Editorial for "Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI". Issue 4 (2nd May 2020) Authors: Kao, Steven; Sung, Kyunghyun Journal: Journal of magnetic resonance imaging Issue: Volume 52:Issue 4(2020) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. Issue 6 (June 2021) Authors: Yap, Timothy A; Nakagawa, Kazuhiko; Fujimoto, Nobukazu; Kuribayashi, Kozo; Guren, Tormod Kyrre; Calabrò, Luana; Shapira-Frommer, Ronnie; Gao, Bo; Kao, Steven; Matos, Ignacio; Planchard, David; Chatterjee, Arkendu; Jin, Fan; Norwood, Kevin; Kindler, Hedy L Journal: Lancet Issue: Volume 9:Issue 6(2021) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab. Issue 21 (16th September 2022) Authors: Nindra, Udit; Shahnam, Adel; Stevens, Samuel; Pal, Abhijit; Nagrial, Adnan; Lee, Jenny; Yip, Po Yee; Adam, Tamiem; Boyer, Michael; Kao, Steven; Bray, Victoria Journal: Thoracic cancer Issue: Volume 13:Issue 21(2022) Page Start: 3058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗